ACETO Corp (ACET) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
ACETO Reports Fiscal 2018 First Quarter Results
November 2, 2017 5:00 PM EDTPORT WASHINGTON, N.Y., Nov. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2018 ended September 30, 2017.
First Quarter Fiscal 2018 versus First Quarter Fiscal 2017
Net sales of $185.3 million versus $128.0 million, a 44.7% increaseGross profit of $40.0 million versus $30.8 million, a 29.7% increaseNet income of $0.5 million versus $4.4 million, a 89.6% decreaseDiluted EPS of $0.01 versus $0.15, an 93.3% decreaseNon-GAAP Adjusted Net Income of $10.7 million versus $8.3 million, a... More